Published in
Wiley, Journal of Internal Medicine, 1(286), p. 63-74, 2019
DOI: 10.1111/joim.12882
Links
Tools
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
Journal article published in 2019 by
S. Bringhen 
,
A. Milan,
M. D'Agostino,
C. Ferri,
R. Wäsch,
F. Gay ,
A. Larocca ,
M. Offidani,
S. Zweegman,
E. Terpos,
H. Goldschmidt,
M. Cavo ,
H. Ludwig,
C. Driessen,
H. W. Auner
and other authors.
,
A. Milan,
M. D'Agostino,
C. Ferri,
R. Wäsch,
F. Gay ,
A. Larocca ,
M. Offidani,
S. Zweegman,
E. Terpos,
H. Goldschmidt,
M. Cavo ,
H. Ludwig,
C. Driessen,
H. W. Auner
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 